Buprenorphine Hcl And Naloxone Hcl 50268-0145
Generic: Buprenorphine And Naloxone
Product NDC
50268-0145- Manufacturer
- Avpak
- Dosage Form
- Tablet
- Route
- Sublingual
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CIII
- Marketing Start
- December 8, 2016
- Listing Expires
- December 31, 2027
- Application
- ANDA203136
Active Ingredients
| Ingredient | Strength |
|---|---|
| Buprenorphine Hydrochloride | 8 mg/1 |
| Naloxone Hydrochloride Dihydrate | 2 mg/1 |
Drug Class
Opioid Antagonist [EPC]Opioid Antagonists [MoA]Partial Opioid Agonist [EPC]
Packaging Options(1)
50 BLISTER PACK in 1 BOX, UNIT-DOSE (50268-145-15) / 1 TABLET in 1 BLISTER PACK (50268-145-11)